Skip to main content

RESIHANCE 40MG

RESIHANCE 40MG

DESCRIPTION

resihance 40mg tablet consist of protein kinase inhibitor with a similar structure to sorafenib. It is hoping to act by prohibiting multiple signalling pathways contains in angiogenesis and tumour growth.
resihance 40mg is commonly given after other chemotherapy have been tried without success.
resihance 40mg tablet which is used as prescription drugs under the supervision of medical practioners.

INDICATION

resihance 40mg is an anticancer drug which is;
• Indicated for the treatment of Hepatocellular carcinoma
• Indicated for the treatment of Colorectal cancer
• Indicated for the treatment of Gastrointestinal stromal tumor.


MECHANISM OF ACTION

Regorafenib(resihance 40mg tablet) consist of systemic therapy which works throughout your body to promote fight certain cancers. Regorafenib belongs to a multikinase inhibitor, may work by stopping some proteins on certain normal and cancer cells. In this way, Regorafenib may inhibit cancers from growing and spreading for a period.
Cancer contains the uncontrolled growth of certain cells in the body.
Regorafenib (resihance 40mg)may interfere with the signals which inform cancer cells to replicate and may slow the cancer from spreading to other parts of the body.
Regorafenib may also block the creation of new blood vessels that feed cancer cells.

DOSAGE MANAGEMENT

Hepatocellular carcinoma :
The resihance 40mg tablet usual dose for Hepatocellular carcinoma is 160mg (four 40mg tablets) Po q Day for the first 21 days of each 28-day cycle.
Follow the treatment of this conditions until disease progression or undesirable toxicity
Colorectal cancer :
The usual dose for Colorectal cancer is 160mg (four 40mg tablets) Po q Day for the first 21 days of each 28-day cycle.
Gastrointestinal stromal tumor :
The usual dose for Gastrointestinal stromal tumor is 160mg (four 40mg tablets) Po q Day for the first 21 days of each 28-day cycle.

PRECAUTION

• Have high risk for HFSR/PPES and rash; a more incidence of HFSR resulted in Asian patients; stop and then reduce or stop regorafenib depending on severity and persistence of dermatologic toxicity.
• While on treatment with resihance 40mg will occur Myocardial ischemia and infarction seen in clinical trials; withhold Resihancefor new or acute cardiac ischemia/infarction and restart only after resolution of acute ischemic events.
• When administrating resihance 40mg tablet, one case report of reversible posterior leukoencephalopathy syndrome (RPLS) occurred (1 of 1100 treated patients); discontinue therapy if RPLS occurs.
• Using resihance 40mg treatment will have Serious drug-induced liver injury with fatal outcome appeared in Resihance-treated patients in clinical trials. Some of the cases, liver dysfunction occurred within the first 2 months of treatment and was characterized by a hepatocellular pattern of injury.
• When administrating resihance 40mg tablet will have heavy risk for haemorrhage; stop therapy for severe or life-threatening haemorrhage
• When administrating Resihance 40mg will have high risk of infections resulted; most common infections includes urinary tract
infections, nasopharyngitis, mucocutaneous and systemic fungal infections and pneumonia

DRUG INTERACTION

Co administration of resihance 40mg tablet with strong CYP3A4 inducers will decrease Regorafenib plasma concentrations and increased plasma concentration of active metabolite M-2; M-5.
Co administration of resihance 40mg  with strong CYP3A4 inhibitor will increase Regorafenib plasma concentration and decreased plasma concentration of active metabolite M-2; M-5.
Co administration of Resihance 40mg with BCRP substrate will increased the plasma concentration of the BCRP substrate.

MISSED DOSE

If dose resihance 40mg  is failed to take, Patients must consult with medical practitioner and follow the instructions given by them.
Hence missed dose must be avoid and follow the regular dosing schedule.

PREGNANCY

Pregnancy category D: The drug has no data available on use in pregnant women. Inform pregnant women about the probable hazard to a foetus

CONTACT US

EMAIL ID : millionhealthpharmaceuticals@gmail.com
PHONE NO : +91-9940472902
WEBSITE URL :https://pillsbag.com/products/resihance
KEYWORDS : resihance, resihance 40mg, resihance 40mg price in India, resihance 40mg tablet


Labels:

Comments

Post a Comment

Popular posts from this blog

Купи Revolade 25mg| Цена Revolade 25mg продукт

REVOLADE  25мг ОПИСАНИЕ Eltrombopag се продава под търговската марка Revolade и е изкуствена форма на протеин, който увеличава производството на тромбоцити (кръвосъсирващи клетки) в тялото ви. Revolade 25мг може да намали риска от кървене чрез увеличаване на тромбоцитите в кръвта. Revolade 25мг капсулы , който се използва като лекарство за предписване под ръководството на медицинските специалисти ПОКАЗАНИЯ Revolade 25 мг е противораково лекарство, което е; Показани за лечение на пациенти с тежка апластична анемия • Първа линия на лечение на тежка апластична анемия • Лечение на рефрактерна тежка апластична анемия Посочени за лечение, за стимулиране на растежа и развитието на тромбоцити в костния мозък Показано е предимно за лечение на пациенти с намален брой тромбоцити поради хронична инфекция с вируса на хепатит С МЕХАНИЗЪМ НА ДЕЙСТВИЕ Елтромбопаг се състои от клас лекарства, известни като агонисти на тромбопоетиновите рецептори. Клас лекарства е група лекарства...
Post a Comment
Read more

Prolia 60mg injection | Denosumab | MHP

PROLIA 60MG DESCRIPTION: Prolia 60mg  is a human monoclonal antibody for the treatment of osteoporosis, treatment-persuaded bone loss, metastases to bone, and giant cell tumor of bone. Prolia 60mg contraindicated in people with low blood calcium levels. Prolia 60mg injection is prescription drug which is used under the guidance of medical oncologist. INDICATION: • Indicated for treatment of osteoporosis at high risk postmenopausal women with (end of menopause/ change of life), whose have serious problem of fractures raised or who failed to other medication of osteoporosis. • Indicated for treatment of Breast cancer in women whose taking certain treatment which make severe their risk of fractures and bone loss in men with prostate cancer. • Indicated for treatment in adults and some adolescents with giant cell tumor of bone which cannot treat with surgery / surgery is not possible is treated with Prolia 60mg injection . MECHANISM OF ACTION: Denosumab mechanism by aim...
Post a Comment
Read more

sovihep D

sovihep D Description The active substance is Sofosbuvir and Daclatasvir ( sovihep d tablet ), which is an inhibitor of the NS5A protein required for the synthesis of HCV. The main purpose of the  sovihep d  is antiviral therapy. It is active in the fight against viral hepatitis C (genotypes 1, 2, 3, 4). The essence of the impact is to block the development of HCV and its spread in the body of the carrier. HCV exists in different forms known as genotypes. Genotype 1 is the most common type of HCV genotype and  sovihep d tablet  is also the most difficult to treat using other treatments. Mechanism of Action: DCV is an HCV NS5A replication complex inhibitor. This NS5A  sovihep d  viral protein has enzymatic activity that is essential for HCV RNA replication and assembly. In replication it appears to play a role in the formation of a membranous web along with viral protein NS4B, and this web provides a platform for replication. The NS5A protein is compo...
Post a Comment
Read more